Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses...

Scientific Reports 2020 / 12 Vol. 10; Iss. 1

Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9

Saqub, Hera, Proetsch-Gugerbauer, Hannah, Bezrookove, Vladimir, Nosrati, Mehdi, Vaquero, Edith M., de Semir, David, Ice, Ryan J., McAllister, Sean, Soroceanu, Liliana, Kashani-Sabet, Mohammed, Osorio,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
10
Journal:
Scientific Reports
DOI:
10.1038/s41598-020-75578-5
Date:
December, 2020
File:
PDF, 2.28 MB
2020
Conversion to is in progress
Conversion to is failed